{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:58:52Z","timestamp":1782989932553,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T00:00:00Z","timestamp":1297468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00277-011-1171-x","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T04:58:09Z","timestamp":1297400289000},"page":"911-916","source":"Crossref","is-referenced-by-count":16,"title":["Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation"],"prefix":"10.1007","volume":"90","author":[{"given":"Martin","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor W.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Tietze-Buerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Gerbitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Uharek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,12]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1099-1069(199906)17:2<45::AID-HON641>3.0.CO;2-6","volume":"17","author":"WY Au","year":"1999","unstructured":"Au WY, Kwong YL, Lie AK, Ma SK, Liang R (1999) Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation. Hematol Oncol 17:45\u201352","journal-title":"Hematol Oncol"},{"key":"1171_CR2","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood.V84.11.3603.bloodjournal84113603","volume":"84","author":"SA Giralt","year":"1994","unstructured":"Giralt SA, Champlin RE (1994) Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 84:3603\u20133612","journal-title":"Blood"},{"key":"1171_CR3","first-page":"1380","volume":"90","author":"JH Lee","year":"2005","unstructured":"Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, Park CJ, Chi HS, Lee MS, Yun S, Lee JS, Lee KH (2005) Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia. Haematologica 90:1380\u20131388","journal-title":"Haematologica"},{"key":"1171_CR4","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1200\/JCO.2006.05.7281","volume":"24","author":"JK Davies","year":"2006","unstructured":"Davies JK, Taussig DC, Oakervee H, Davies AJ, Agrawal SG, Gribben JG, Lister TA, Cavenagh JD (2006) Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia\/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease. J Clin Oncol 24:e23\u2013e25","journal-title":"J Clin Oncol"},{"key":"1171_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.bmt.1702116","volume":"25","author":"S Seo","year":"2000","unstructured":"Seo S, Kami M, Honda H, Kashima T, Matsumura T, Moriya A, Machida U, Kanda Y, Chiba S, Hirai H (2000) Extramedullary relapse in the so-called \u2018sanctuary\u2019 sites for chemotherapy after donor lymphocyte infusion. Bone Marrow Transplant 25:226\u2013227","journal-title":"Bone Marrow Transplant"},{"key":"1171_CR6","first-page":"180","volume":"14","author":"SL Goldberg","year":"1994","unstructured":"Goldberg SL, Mangan KF, Klumpp TR, Cropper TM, Schnall SF, Macdonald JS (1994) Lack of a graft-versus-leukemia effect in an immunologically privileged sanctuary site. Bone Marrow Transplant 14:180\u2013181","journal-title":"Bone Marrow Transplant"},{"key":"1171_CR7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/sj.leu.2403523","volume":"18","author":"SJ Choi","year":"2004","unstructured":"Choi SJ, Lee JH, Lee JH, Kim S, Seol M, Lee YS, Lee JS, Kim WK, Chi HS, Lee KH (2004) Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia 18:1789\u20131797","journal-title":"Leukemia"},{"key":"1171_CR8","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/sj.leu.2401144","volume":"12","author":"C Berthou","year":"1998","unstructured":"Berthou C, Leglise MC, Herry A, Balcon D, Hardy E, Lessard M, Abgrall JF (1998) Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia. Leukemia 12:1676\u20131681","journal-title":"Leukemia"},{"key":"1171_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00686291","volume":"30","author":"MG Donelli","year":"1992","unstructured":"Donelli MG, Zucchetti M, D\u2019Incalci M (1992) Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 30:251\u2013260","journal-title":"Cancer Chemother Pharmacol"},{"key":"1171_CR10","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1200\/JCO.2006.10.0677","volume":"25","author":"ER Gerstner","year":"2007","unstructured":"Gerstner ER, Fine RL (2007) Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol 25:2306\u20132312","journal-title":"J Clin Oncol"},{"key":"1171_CR11","first-page":"801","volume":"17","author":"AN Bekassy","year":"1996","unstructured":"Bekassy AN, Hermans J, Gorin NC, Gratwohl A (1996) Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and chronic leukemia working parties of the European group for blood and marrow transplantation. Bone Marrow Transplant 17:801\u2013808","journal-title":"Bone Marrow Transplant"},{"key":"1171_CR12","doi-asserted-by":"crossref","unstructured":"Beillard E, Pallisgaard N, van dV, V, Bi W, Dee R, van der SE, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program. Leukemia 17:2474\u20132486","DOI":"10.1038\/sj.leu.2403136"},{"key":"1171_CR13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00277-007-0294-6","volume":"86","author":"IW Blau","year":"2007","unstructured":"Blau IW, Schmidt-Hieber M, Leschinger N, Goldner H, Knauf W, Hopfenmuller W, Thiel E, Blau O (2007) Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation. Ann Hematol 86:583\u2013589","journal-title":"Ann Hematol"},{"key":"1171_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2498.x","volume":"77","author":"N Meuleman","year":"2006","unstructured":"Meuleman N, Ahmad I, Duvillier H, Lemort M, Bennani J, Martiat M, Lagneaux L, Bron D (2006) Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report. Eur J Haematol 77:523\u2013526","journal-title":"Eur J Haematol"},{"key":"1171_CR15","unstructured":"Thiel E, Blau IW, Neumann M, Tietze-B\u00fcrger C, Gerbitz A, Uharek L (2008) Treatment of leukemic meningeosis by CD14 depleted adoptive intrathecal cell therapy [abstract]. Blood 112."},{"key":"1171_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2004-861537","volume":"24","author":"A Saiz","year":"2004","unstructured":"Saiz A, Graus F (2004) Neurological complications of hematopoietic cell transplantation. Semin Neurol 24:427\u2013434","journal-title":"Semin Neurol"},{"key":"1171_CR17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.STR.30.8.1651","volume":"30","author":"CS Padovan","year":"1999","unstructured":"Padovan CS, Bise K, Hahn J, Sostak P, Holler E, Kolb HJ, Straube A (1999) Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke 30:1651\u20131656","journal-title":"Stroke"},{"key":"1171_CR18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1212\/WNL.56.8.1106","volume":"56","author":"CS Padovan","year":"2001","unstructured":"Padovan CS, Gerbitz A, Sostak P, Holler E, Ferrara JL, Bise K, Straube A (2001) Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology 56:1106\u20131108","journal-title":"Neurology"},{"key":"1171_CR19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","volume":"26","author":"B Engelhardt","year":"2005","unstructured":"Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485\u2013495","journal-title":"Trends Immunol"},{"key":"1171_CR20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pharmthera.2005.11.007","volume":"111","author":"E Pedemonte","year":"2006","unstructured":"Pedemonte E, Mancardi G, Giunti D, Corcione A, Benvenuto F, Pistoia V, Uccelli A (2006) Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. Pharmacol Ther 111:555\u2013566","journal-title":"Pharmacol Ther"},{"key":"1171_CR21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cyto.a.20225","volume":"69","author":"TO Kleine","year":"2006","unstructured":"Kleine TO, Benes L (2006) Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Cytom A 69:147\u2013151","journal-title":"Cytom A"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1171-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1171-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1171-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T13:32:23Z","timestamp":1592314343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1171-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,12]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1171-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,12]]}}}